Post COVID-19 diebetes discharge pathway – risk stratification and follow up guidance for people being discharged from secondary care after COVID-19 infection (ABCD)
Diabetes News
Tag: COVID ‐19
Use of Dipeptidyl Peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study
These data support the safety of DPP‐4 inhibitors for diabetes management during the COVID‐19 pandemic and they should not be discontinued (Diabetes, Obesity and Metabolism)
Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study
Lockdown determined a relevant short-term metabolic worsening in approximately one-fourth of previously well-controlled type 2 diabetic individuals; pre-lockdown triglycerides were the only parameter able to predict such derangement of glucose control (Acta Diabetologica)
COVID-19 and Type 1 Diabetes: Challenges and actions
The authors of this commentary are involved in the care of T1D in LMICs and see services in such settings suffering in three major ways from the impacts of COVID-19 (Diabetes Research and Clinical Practice)
ABCD issues Recovery Guidance
A Quick guidance to Risk Stratification and recovery of Diabetes Services in the post – Covid-19 Era (ABCD)
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID ‐19 pandemic
The aim of this manuscript is to comprehensively summarize the current knowledge on the antihyperglycemic properties of HCQ and to critically evaluate the potential risks and benefits related to HCQ use in patients with diabetes, even in light of the current pandemic scenario (Journal of Diabetes)
Glycosmedia is also available as an App: